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Background: Health conditions in people with spinal cord 
injury are major determinants for disability, reduced well-
being, and mortality. However, population-based evidence 
on the prevalence and treatment of health conditions in peo-
ple with spinal cord injury is scarce.
Objective: To investigate health conditions in Swiss residents 
with spinal cord injury, specifically to analyse their preva-
lence, severity, co-occurrence, and treatment.
Methods: Cross-sectional data (n = 1,549) from the commu-
nity survey of the Swiss Spinal Cord Injury (SwiSCI) co-
hort study, including Swiss residents with spinal cord injury 
aged over 16 years, were analysed. Nineteen health condi-
tions and their self-reported treatment were assessed with 
the spinal cord injury Secondary Conditions Scale and the 
Self-Administered Comorbidity Questionnaire. Prevalence 
and severity were compared across demographics and spinal 
cord injury characteristics. Co-occurrence of health condi-
tions was examined using a binary non-metric dissimilarity 
measure and multi-dimensional scaling. Treatment rates 
were also examined.
Results: Number of concurrent health conditions was high 
(median 7; interquartile range 4–9; most frequent: spastic-
ity, chronic pain, sexual dysfunction). Prevalence of health 
conditions increased with age and was higher in non-trau-
matic compared with traumatic spinal cord injury. Spinal 
cord injury specific conditions co-occurred. Relative fre-
quencies of treatment were low (median 44%, interquartile 
range 25–64%), even for significant or chronic problems. 
Discussion: A high prevalence of multimorbidity was found 
in community-dwelling persons with spinal cord injury. 
Treatment for some highly prevalent health conditions was 
infrequent.
Key words: spinal cord injury; community survey; secondary 
health conditions; comorbidity; multimorbidity; risk factors; 
treatment.
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INTRODUCTION
Health conditions (HCs) after spinal cord injury (SCI) are 
common and are regarded as major determinants for disability, 
reduced life satisfaction and emotional well-being (1), as well 
as mortality and diminished life expectancy (2). These HCs 
comprise a variety of physical or psychological diagnoses 
and symptoms that are direct or indirect consequences of 
impairments, activity limitations and participation restrictions 
and, in that sense, have been referred to as “secondary” HCs 
(3). Typical and frequent “secondary” HCs include chronic 
nociceptive and neuropathic pain, spasticity, urinary tract 
and pulmonary infections, circulatory problems, osteoporosis 
and related fractures, bowel and bladder regulation problems, 
sexual dysfunction, and pressure ulcers (4, 5). In addition, 
people living with SCI may incur a heightened risk of chronic 
diseases associated with the general ageing process, including 
cardiovascular disease, diabetes, cancer and depression (5). 
Yet, the attributable risk for such HCs to SCI, as reflected in 
the relative risk in comparison with the general population, 
is poorly documented. Apart from their immediate impact 
on the daily lives of people with SCI, the occurrence of HCs 
may induce considerable added economic expense, including 
direct costs for diagnosis, treatment and hospitalization (6, 7), 
as well as indirect costs, in particular lost earnings and early 
retirement, that often exceed direct costs (8).
Prevention measures and appropriate treatment may reduce 
the incidence and impact of many of these HCs after SCI (9). 
To inform and optimize health policy programmes aiming at 
reducing the impact of prevalent morbidity after SCI, there is a 
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need for contemporary evidence on the prevalence and severity 
of HCs as well as their treatment. To arrive at a comprehensive 
picture of the prevalence of HC in SCI multiple stakeholder 
perspectives must be considered. While data on inpatient and 
outpatient treatments by diagnoses, based on the World Health 
Organization’s International Classification of Diseases (ICD), 
provide valuable information from health professionals’ per-
spective (10), a patient-centred, community-based approach 
focuses on relevant subjectively experienced HCs. There is 
currently a lack of community-based studies that could help 
informed decision-making and planning. In the present paper, 
data from the community survey of the Swiss Spinal Cord In-
jury (SwiSCI) Cohort Study (11, 12) were used to investigate 
HCs experienced by community-dwelling people with SCI in 
Switzerland. The specific aims of this study were to analyse: 
(i) the overall and group-specific prevalence of HCs; (ii) their 
severity; (iii) potential clustering of particular types of HCs; 
and (iv) their treatment, as reported by survey respondents.
METHODS
Design
Data from the cross-sectional, population-based community survey of 
the SwiSCI Cohort Study (11) were analysed. The SwiSCI community 
survey followed a modular structure and is described in detail in an ac-
companying paper (12). Data were collected by written or online ques-
tionnaires, and in special cases, by telephone interviews. The SwiSCI 
community survey was formally approved by the respective regional 
medical ethics committees. All participants provided written consent 
for anonymous use of their responses for the purpose of the study.
Sample
The survey was performed between late 2011 and early 2013 and 
included Swiss residents with a traumatic or non-traumatic SCI aged 
16 years and older. Persons with congenital conditions leading to SCI, 
SCI in the context of palliative care, neurodegenerative disorders, 
and Guillain-Barré syndrome were excluded from the study. The 
SwiSCI population was recruited through the national association for 
persons with SCI (Swiss Paraplegic Association), 3 specialized SCI-
rehabilitation centres, and a SCI-specific home care institution (11). 
In an accompanying paper in this issue we have provided a detailed 
description of the study protocol, the procedures for recruiting par-
ticipants, characteristics of the study population, non-response bias 
and data quality of the SwiSCI community survey 2012 (12). This 
descriptive analysis shows that the design was efficient in recruiting 
1,549 persons for the 2 core modules of the survey (Starter and Basic 
modules), which represented 49.3% of the sampled population. Re-
sponse bias with respect to available person and SCI characteristics 
was limited and had minor impact on a variety of survey results. Self-
reported demographics (gender; age) and SCI characteristics (year of 
SCI; lesion level; lesion severity) further showed good consistency 
with available medical record data. For this paper, data from the Starter 
Module and the Basic Module were used (12). 
Measures
Demographic information included gender, age at the time of the 
questionnaire (in years), duration of formal education (in years), and 
language of response to the questionnaire (German, French or Italian). 
Adhering to International Spinal Cord Society (ISCoS) recommenda-
tions (13, 14), the following age groups were derived: 16–30, 31–45, 
46–60, 61–75, and 76 years or older. To overcome issues of small cell 
counts in stratified analysis, the highest age groups were combined into 
a single age group comprising those aged 61 years or older. 
Lesion characteristics included SCI aetiology, lesion group, and 
time since SCI diagnosis (in years). SCI aetiology was classified as 
traumatic or non-traumatic. Lesion group combined information on 
level and completeness of the lesion into the following 4 injury classes: 
incomplete paraplegia, complete paraplegia, incomplete tetraplegia, 
and complete tetraplegia. In deriving groups by time since injury, 
we considered using the cut-offs recommended by ISCoS (13, 14), 
but due to the small numbers of participants in some categories, we 
recombined and created the following groups for use in stratified 
analysis (in years): less than 6, 6–15, 16– 25, and 26 years or more.
Nineteen HCs and their treatment were assessed. Specific condi-
tions that are commonly encountered by people living with SCI were 
included, as well as HCs that are highly prevalent in the general popula-
tion (referred to as general HCs from here on) The Spinal Cord Injury 
Secondary Conditions Scale (SCI-SCS) (15) and the Brief International 
Classification of Functioning, Disability and Health (ICF) Core Sets for 
SCI (16, 17) were used as reference for the SCI-specific HCs. The SCI-
SCS provides a reliable and valid scale for the assessment of specific HCs 
associated with SCI that directly and indirectly impact health and physi-
cal functioning (15). Assessment of impact refers to the past 3 months 
and is made on a 4-point Likert scale, with ordinal levels “not existing 
or insignificant”; “mild or infrequent”; “moderate or occasional”; and 
“significant or chronic”. A selection of 15 HCs and their severity was 
evaluated, including chronic pain; sexual dysfunction; spasticity; circu-
latory problems; bladder dysfunction; bowel dysfunction; contractures; 
urinary tract infections; autonomic dysreflexia; postural hypotension; 
injury caused by loss of sensation; respiratory problems; pressure ul-
cers; heterotopic ossification; and sleep disorders. Sleep disorders were 
added based on the Brief ICF Core Sets for SCI. To promote accurate 
reporting, participants were provided with descriptions of the distinctive 
symptoms and signs of a given HC. These descriptions were based on 
the original SCI-SCS, but simplified, shortened or disregarded, where 
judged appropriate, to shorten the questionnaire. A detailed description 
of the HCs used in SwiSCI compared with the SCI-SCS is provided in 
Appendix I. In addition, the presence of 4 general HCs, including heart 
disease, depression, diabetes and cancer was evaluated. Those conditions 
were evaluated on a binary scale using the Self-Administered Comorbid-
ity Questionnaire (SCQ), posing the question “Do you have ‘…’?” for 
each of the general HCs with response options “Yes” and “No”. The 
SCQ is an efficient method with good reliability and validity for the 
assessment of comorbid conditions in the absence of medical records 
(18). Participants who indicated having a diagnosis (SCQ items) or a 
relevant HC (SCI-SCS items) were further asked whether they received 
treatment for it (“yes”/”no”). 
Statistical analyses 
Statistical analysis was performed using statistical packages Stata, 
version 13.1, and R, version 3.1.0.
Basic statistical procedures were used to describe the study 
population as well as the distribution of HCs. Using univariable 
analysis (variation of outcome by 1 explanatory variable), we further 
evaluated the prevalence of existing or significant HCs by participant 
characteristics. For that purpose, HCs that were evaluated with the 
SCI-SCS 4-point Likert scale were dichotomized into “not existing 
or insignificant” (i.e. the lowest level of the Likert scale) and “exist-
ing and relevant” (i.e. the 3 upper levels of the Likert scale). In case 
of participant characteristics with multiple levels, including age at 
time of the survey (4 groups), lesion group (4 groups) and time since 
injury (4 groups) we used post-hoc analysis, featuring contrasts with 
Bonferroni correction for multiple comparisons, to decompose overall 
associations in prevalence for a given HC into meaningful subgroups. 
For selected HCs that are characteristically reliant on self-report (e.g. 
chronic pain or sleep problems) multivariable analysis with distinct 
primary determinants, mediators and moderators to evaluate adjusted 
associations are in progress for later publication. 
For the selection of 15 HCs that are considered specific to SCI we 
evaluated multimorbidity as the summary score (range 0–15). Unadjust-
ed and adjusted incidence rate ratios were estimated for demographic 
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variables (gender, age) and lesion characteristics (lesion class, lesion 
type, time since injury) using negative binomial regression modelling 
in order to account for overdispersion in the count data. A graphical 
evaluation of the co-occurrence of reported HCs was performed. For 
that purpose, the similarity of all pairs of current HCs was computed 
using a binary count of their simultaneous or separate occurrence. The 
resulting similarity measure for each person was then transformed into 
a single measure of mutual relationship between pairs of current HCs 
using the binary Lance-Williams non-metric dissimilarity measure (19). 
The Lance-Williams method is appropriate for the descriptive analysis 
of multimorbidity in people with SCI, which presumably arises from 
multiple sequels of the primary condition, implying a hierarchical 
algorithm. The Lance-Williams algorithm provides a flexible method 
to conserve the original space between clusters of HCs as much as pos-
sible (20). To facilitate 2-dimensional graphical display the similarity 
matrix was mapped onto a 2-dimensional coordinate system using 
multidimensional scaling (21). Using a bubble plot, the likelihood of 
the co-occurrence of any HC is indicated by the spatial position on 
the chart, relative to the respective position of all other HCs, while the 
bubble size proportionally indicates the overall prevalence of the HC. 
Finally, the proportion of persons who indicated not receiving treat-
ment for a relevant (SCI-SCS) or existing (SCQ) HC was assessed. 
For items that were evaluated according to the SCI-SCS, the propor-
tion (with binomial 95% confidence interval) of persons receiving 
treatment was further evaluated separately for the group indicating a 
significant or chronic HC. 
While all basic descriptive analysis were performed on the complete 
case data, ignoring missing data, we statistically accounted for both 
unit non-response as well as item non-response in all uni-variable 
analyses (22). Selective unit non-response, implying differential non-
participation of persons with certain demographic or lesion character-
istics who were contacted for participation, was handled through the 
use of inverse probability weights derived from the propensity scores 
for survey participation. The range of the inverse probability weights 
used in weighted analyses, which indicates the span in sampling 
weight for persons most over-represented and most under-represented, 
was 0.65–1.80 (12). Item non-response, implying missing values in 
explanatory variables or outcomes, was handled using a random forest 
imputation technique (R-package missForest (23)).
RESULTS
Table I shows descriptive characteristics of the 1549 study 
participants. The majority of the sample was male and the 
median age was 52 years. The youngest (16–30 years) and the 
oldest (76 years or older) age groups made up 8.3% and 6.1% 
of participants, respectively. The median length of education 
was 13 years, signifying upper secondary education including 
additional education after SCI as part of an adapted vocational 
reintegration programme. German was the predominant lan-
guage of response; the relative size of the language groups is 
reflective of the Swiss general population. More than three-
quarters (78.4%) of the participants reported a traumatic SCI 
aetiology. Overall, 69.2% of the participants were classified 
as having paraplegia, with 58.0% having incomplete lesions. 
The median time since injury was 14 years, with approximately 
one-quarter of participants reporting living with SCI for more 
than 25 years. The extent of missing information was between 
0% (complete reporting; for gender, age, and language (by 
default) and 2.1% (for years of education)).
Approximately 75% (n = 1,166) of participants provided a 
complete report on the severity of all of the 19 HCs posed in 
the questionnaire. Additional proportions, of 15.4% (n = 238) 
and 7.7% (n = 120), reported 15–18 and 1–14 HCs, respectively. 
The remaining 1.6% (n = 25) of participants did not provide 
any information. The median number of HCs that were at least 
of second-level severity (i.e. at least “mild severity” or “infre-
quent occurrence”) was 7, and this estimate was not affected 
by the overall completeness of reporting on HCs (Table I).
Fig. 1 shows the combined prevalence of HCs that were 
reported by the study population as mild or infrequent, moder-
ate or occasional, or significant or chronic. The leading HCs 
included spasticity (74%), chronic pain (73.2%), and sexual 
dysfunction (67.5%). Cancer (3.6%), diabetes (6.6%) and het-
erotopic ossification (6.6%) were the least-often reported HCs. 
Sexual dysfunction was the HC most often reported as signifi-
cant or chronic (43.6%), followed by chronic pain (36.6%), 
bladder dysfunction (26.3%) and spasticity (24%) (Table 
II). Although many individuals reported issues with bowel 
dysfunction (66.2%), the largest proportion reported having 
mild or infrequent issues (24.0%) compared with moderate or 
occasional (21.6%) and significant or chronic issues (20.6%). 
Table I. Characteristics of study participants (n = 1549) 
Characteristic [n missing]
Gender, n (%)
Male 1,107 (71.5)
Female 442 (28.5)
Age, years, median (IQR) 52 (42–63)
16–30 years 129 (8.3)
31–45 years 377 (24.3)
46–60 years 571 (36.9)
61–75 years 378 (24.4)
≥ 76 years 94 (6.1)
Years of education [32], median (IQR) 13 (12–15)
Language, n (%)
German 1,105 71.3)
French 376 (24.3)
Italian 68 (4.4)
Aetiology [15], n (%)
Traumatic 1,202 (78.4)
Non-traumatic 332 (21.6)
Lesion characteristics [12], n (%)
Paraplegia, incomplete 577 (37.5)
Paraplegia, complete 486 (31.6)
Tetraplegia, incomplete 314 (20.4)
Tetraplegia, complete 160 (10.4)
Time since injury, years, [27], median (IQR) 14 (6–25)
< 1 years 24 (1.6)
1–5 years 284 (18.7)
6–10 years 263 (17.3)
11–15 years 230 (15.1)
16–20 years 173 (11.4)
21–25 years 159 (10.4)
26–30 years 133 (8.7)
31–35 years 93 (6.1)
≥ 36 years 163 (10.7)
Health conditions (HC) [25], median (IQR)
Number of HCs reported on (maximum = 19) 19 (19–19)
Number of HCs, overall 7 (4–9)
Number of HCs, in sample reporting on all 7 (5–9)
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Demographic characteristics
Many HCs varied according to demographic characteristics (Table 
III). Regarding gender, the largest contrasts with higher prevalence 
of health problems in females were found for bladder dysfunction, 
circulatory problems and depression. Males more often reported 
sexual dysfunction, pressure ulcers and diabetes. The variation by 
age group was even more pronounced, with significant contrasts 
for 10 out of 19 HCs. The prevalence of reported health issues 
was lower in the youngest age group (16–30 years) than in the 
oldest age group (61 years or older) for chronic pain, contractures, 
circulatory problems, respiratory problems, heart disease, diabetes 
and cancer. Depending on the HC, intermediate age groups were 
Table II. Prevalence and severity of reported health conditions
Health condition
Severity of a health condition problem 
n [missing]
Not existing or 
insignificant
n (%)
Mild or  
infrequent
n (%)
Moderate or 
occasional
n (%)
Significant or 
chronic
n (%)
Spasticity 1,436 [113] 374 (26.0) 319 (22.2) 399 (27.8) 344 (24.0)
Chronic pain 1,445 [104] 387 (26.8) 224 (15.5) 305 (21.1) 529 (36.6)
Sexual dysfunction 1,374 [175] 447 (32.5) 140 (10.2) 188 (13.7) 599 (43.6)
Bowel dysfunction 1,444 [105] 488 (33.8) 347 (24.0) 312 (21.6) 297 (20.6)
Bladder dysfunction 1,427 [122] 505 (35.4) 298 (20.9) 248 (17.4) 376 (26.3)
Urinary tract infection 1,423 [126] 582 (40.9) 262 (18.4) 327 (23.0) 252 (17.7)
Sleep disorders 1,456 [93] 600 (41.2) 303 (20.8) 341 (23.4) 212 (14.6)
Contractures 1,440 [109] 704 (48.9) 227 (15.8) 251 (17.4) 258 (17.9)
Circulatory problems 1,421 [128] 862 (60.6) 278 (19.6) 169 (11.9) 112 (7.9)
Pressure sores 1,386 [163] 905 (65.3) 218 (15.7) 148 (10.7) 115 (8.3)
Autonomic dysreflexia 1,417 [132] 1,010 (71.3) 206 (14.5) 139 (9.8) 62 (4.4)
Injury caused by loss of sensation 1,434 [115] 1,057 (73.7) 228 (15.9) 111 (7.7) 38 (2.7)
Respiratory problems 1,447 [102] 1,107 (76.5) 171 (11.8) 103 (7.1) 66 (4.6)
Postural hypotension 1,412 [137] 1,106 (78.3) 184 (13.0) 93 (6.6) 29 (2.1)
Heterotopic ossification 1,396 [153] 1,304 (93.4) 49 (3.5) 23 (1.7) 20 (1.4)
Existing health condition diagnosis? 
n [missing]
No
n (%)
Yes
n (%)
Depression 1,474 [75] 1,244 (84.4) 230 (15.6)
Coronary heart disease 1,488 [61] 1,351 (90.8) 137 (9.2)
Diabetes 1,495 [54] 1,397 (93.4) 98 (6.6)
Cancer 1,488 [61] 1,435 (96.4) 53 (3.6)
Fig. 1. Prevalence of reported health condition problems and existing diagnoses. 95% CI: 95% confidence interval.
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more similar to the highest age group (e.g. chronic pain) or the 
lowest age group (e.g. respiratory problems, heart disease). The 
age group 46–60 years reported a higher prevalence of issues 
with sexual dysfunction and sleep than the younger or older age 
groups, while the high rate of issues regarding postural hypoten-
sion in the youngest age group significantly contrasted with the 
lower rates in all older age groups. 
Lesion characteristics
Reporting of many HCs also varied by lesion characteristics, 
with notable contrasts in 12 out of 19 HCs (Table IV). Post-
hoc analysis of contrasts indicated differences due to lesion 
level, but not lesion completeness for sexual dysfunction and 
bladder dysfunction, with higher prevalence of health problems 
following paraplegia than tetraplegia. Likewise, yet conversely, 
circulatory problems, autonomic dysreflexia, respiratory prob-
lems and postural hypotension were more prevalent in people 
with tetraplegia than in those with paraplegia. Other HCs, such 
as urinary tract infection and pressure ulcers, differed by lesion 
severity rather than lesion level, with higher overall preva-
lence of HCs in complete than incomplete lesions. Similarly, 
yet conversely, reporting of contractures and depression was 
more frequent in the group with incomplete lesions. Contrasts 
in the reporting of spasticity and chronic pain were due to 
the combined effect of level and completeness of the lesion. 
The tetraplegia-incomplete group reported markedly higher 
prevalence of spasticity, while the tetraplegia-complete group 
reported lower levels of chronic pain than the other 3 groups.
Aetiology
With respect to aetiology of SCI, there were 9 out of 19 sta-
tistically significant contrasts, which, in all cases, signified 
Table III. Relative frequency of reported health condition problems and diagnoses stratified by demographic characteristics of participants
Health condition
Gender Age at time of questionnaire
Male
% (95% CI)
Female
% (95% CI) p
16–30 years
% (95% CI)
31–45 years
% (95% CI)
46–60 years
% (95% CI)
≥ 61 years
% (95% CI) p
Spasticity 71.2 
(68.4–73.9)
72.2 
(67.7–76.3)
0.70 76.0 
(67.5–82.8)
70.6 
(65.7–75.1)
68.7 
(64.6–72.5)
74.1 
(69.8–78.0)
0.19
Chronic pain 70.5 
(67.7–73.2)
74.1 
(69.7–78.0)
0.17 53.9 
(45.2–62.5)
69.5 
(64.6–74.1)
74.6 
(70.7–78.1)
74.0 
(69.8–77.9)
< 0.001
Sexual dysfunction 69.4 
(66.5–72.1)
50.8 
(46.0–55.6)
< 0.001 60.5 
(51.6–68.7)
59.5 
(54.3–64.5)
69.9 
(65.9–73.7)
61.6 
(56.9–66.0)
0.005
Bowel dysfunction 61.5 
(58.5–64.4)
67.2 
(62.5–71.5)
0.043 67.2 
(58.5–74.8)
61.6 
(56.4–66.5)
64.6 
(60.5–68.6)
61.9 
(57.3–66.3)
0.57
Bladder dysfunction 59.3 
(56.2–62.2)
67.4 
(62.7–71.8)
0.004 57.2 
(48.3–65.6)
58.6 
(53.4–63.6)
62.9 
(58.7–66.9)
63.8 
(59.2–68.1)
0.31
Urinary tract infection 53.7 
(50.6–56.7)
58.5 
(53.7–63.1)
0.10 60.7 
(51.8–69.0)
55.7 
(50.5–60.8)
56.6 
(52.3–60.7)
51.6 
(46.9–56.2)
0.23
Sleep 55.5 
(52.5–58.5)
60.9 
(56.1–65.4)
0.062 51.6 
(42.8–60.2)
52.3 
(47.2–57.4)
62.0 
(57.9–66.0)
56.7 
(52.0–61.2)
0.016
Contractures 50.5 
(47.4–53.5)
52.7 
(48.0–57.5)
0.43 42.1 
(33.7–51.0)
41.4 
(36.5–46.6)
51.9 
(47.7–56.1)
60.0 
(55.4–64.5)
< 0.001
Circulatory problems 34.1 
(31.3–37.0)
46.4 
(41.6–51.1)
< 0.001 25.9 
(18.9–34.3)
30.6 
(26.1–35.4)
39.8 
(35.7–43.9)
43.9 
(39.4–48.6)
< 0.001
Pressure sores 34.1 
(31.3–37.0)
28.8 
(24.7–33.3)
0.053 29.1 
(21.8–37.6)
30.0 
(25.6–34.9)
32.9 
(29.1–37.0)
34.9 
(30.5–39.4)
0.42
Autonomic dysreflexia 27.4 
(24.7–30.1)
28.1 
(24.0–32.6)
0.77 29.2 
(21.9–37.8)
26.6 
(22.3–31.4)
31.1 
(27.3–35.1)
24.1 
(20.4–28.3)
0.10
Injury caused by loss of sensation 25.0 
(22.5–27.7)
23.3 
(19.5–27.5)
0.49 24.8 
(18.1–33.0)
26.4 
(22.1–31.1)
26.8 
(23.2–30.7)
20.4 
(17.0–24.4)
0.10
Respiratory problems 23.3 
(20.8–25.9)
21.8 
(18.1–26.0)
0.53 19.1 
(13.0–27.3)
17.0 
(13.5–21.2)
21.0 
(17.7–24.6)
30.4 
(26.3–34.8)
< 0.001
Postural hypotension 19.6 
(17.3–22.1)
23.3 
(19.5–27.6)
0.12 30.7 
(23.3–39.4)
19.9 
(16.0–24.3)
18.9 
(15.8–22.4)
20.9 
(17.4–25.0)
0.033
Heterotopic ossification 6.6 
(5.2–8.3)
4.7 
(3.0–7.2)
0.18 2.7 
(1.0–7.1)
5.4 
(3.5–8.4)
6.0 
(4.3–8.4)
7.3 
(5.2–10.0)
0.26
Depression 13.1 
(11.2–15.3)
23.4 
(19.5–27.8)
< 0.001 11.5 
(6.8–18.6)
16.6 
(13.1–20.8)
15.3 
(12.5–18.7)
17.8 
(14.4–21.7)
0.39
Coronary heart disease 9.4 
(7.7–11.3)
9.0 
(6.6–12.2)
0.85 5.7 
(2.8–11.5)
5.0 
(3.2–7.8)
7.6 
(5.6–10.2)
15.3 
(12.2–19.0)
< 0.001
Diabetes 7.6 
(6.1–9.5)
4.6 
(2.9–7.0)
0.039 0 
(–)
2.6 
(1.3–5.0)
5.3 
(3.7–7.5)
13.1 
(10.3–16.7)
< 0.001
Cancer 3.1 
(2.2–4.3)
4.2 
(2.7–6.5)
0.28 0 
(–) 
1.3 
(0.4–3.1)
3.2 
(1.9–4.9)
6.4 
(4.3–8.9)
< 0.001
95% CI: 95% confidence interval.
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a higher prevalence of HCs in the group with non-traumatic 
SCI (Table IV). Finally, contrast analyses revealed systematic 
variation in the reporting of problems with time since injury. 
The reporting of issues with spasticity was more frequent in the 
group with the shortest time since injury (≤ 5 years) than in any 
of the groups with longer time since injury (at least 6 years). 
Similarly, the higher reporting of depression in the groups 
with shortest time since injury (< 5 and 6–15 years) contrasted 
with the lower reporting in the groups with longest time since 
injury (16–25 and 26 years or more). Reporting of injury due 
to loss of sensation was less frequent in the group with the 
shortest duration since SCI only while it was elevated in the 
3 other groups with longer time since injury (6–15, 16–25, 
and 26 years or more). Finally, the prevalence of circulatory 
problems in the group with shortest time since SCI was lower 
than in the group with the longest time since injury, while the 
other groups showed an intermediate level.
Multimorbidity
The mean number of concurrently reported SCI-specific HCs 
varied between 6.3 and 7.1 across the strata of demographic and 
SCI-related variables. Multimorbidity (range 0–15) varied with 
age, lesion characteristics, aetiology, and time since injury, but 
not with gender. Only the variation with lesion characteristics 
and aetiology was confirmed in the adjusted analysis (Table 
V). Participants with a paraplegic-complete or either tetra-
plegic lesion have an 11–13% higher expected count of HCs 
than those with a paraplegia-incomplete lesion. In addition, 
persons with a non-traumatic aetiology are expected to report 
11% more concurring HCs than those with a traumatic lesion. 
Co-occurrence of health conditions
Multidimensional scaling of the co-occurrence of HCs revealed 
a clear clustering of the most common conditions, including 
sexual dysfunction, spasticity, bowel dysfunction, chronic 
pain, bladder dysfunction and urinary tract infections. Indi-
vidual HCs adjacent to this cluster included sleep disorders, 
contractures, circulatory problems, followed by injury due to 
loss of sensation, pressure ulcers and autonomic dysreflexia. 
The reporting of general HCs, including heart disease, cancer, 
depression and diabetes, was weakly associated with any other 
specific HC (Fig. 2).
Treatment 
Finally, we investigated whether persons who reported a 
HC received treatment for that HC. The median number of 
treatments reported per individual was 3 (interquartile range 
(IQR) 1–5) and the median proportion of HCs treated was 44% 
(IQR 25–64%). Not receiving treatment was least frequently 
reported for general HCs, ranging from 3.9% to 25.2% for heart 
disease and depression, respectively. In comparison, absence 
of treatment among the specific HCs that are closely linked to 
SCI ranged from 26.7% for urinary tract infection to 85.5% 
for sexual dysfunction. Other HCs with high reporting of non-
treatment included postural hypotension (75.9%), injury caused 
by loss of sensation (73.3%), autonomic dysreflexia (68.9%) 
and sleep disorders (69.4%). Restricting the breakdown to 
HCs that were reported as significant or chronic only, size-
able rates for absence of treatment were generally confirmed, 
particularly for sexual dysfunction (85.5%), sleep disorders 
(49.8%), autonomic dysreflexia (48.3%), and, although with 
Table V. Relative risk of multimorbidity for self-reported SCI-specific conditions (sum-score ranging 0–15) in relation to demographics and lesion 
characteristics
Parameter n Mean (95% CI) Unadjusted IRR (95% CI) p Adjusted IRR (95% CI) p
Gender 0.37 0.49
Male 1,107 6.6 (6.4–6.8) 1 1
Female 442 6.8 (6.5–7.2) 1.03 (0.97–1.09) 1.02 (0.96–1.09)
Age at questionnaire 0.02 0.14
16–30 years 129 6.3 (5.7–7.0) 1 1
31–45 years 377 6.3 (5.9–6.6) 0.99 (0.89–1.11) 0.99 (0.88–1.11)
46–60 years 571 6.9 (6.6–7.2) 1.09 (0.98–1.21) 1.07 (0.96–1.20)
≥ 61 years 472 6.9 (6.5–7.2) 1.09 (0.97–1.21) 1.06 (0.95–1.19)
Lesion characteristics 0.047 0.006
Paraplegia, incomplete 584 6.4 (6.1–6.6) 1 1
Paraplegia, complete 488 6.9 (6.6–7.2) 1.09 (1.02–1.16) 1.11 (1.04–1.19)
Tetraplegia, incomplete 316 6.9 (6.4–7.3) 1.08 (1.00–1.17) 1.11 (1.02–1.20)
Tetraplegia, complete 161 6.9 (6.3–7.5) 1.09 (0.99–1.20) 1.13 (1.02–1.25)
Aetiology 0.012 0.003
Traumatic 1,215 6.5 (6.3–6.8) 1 1
Non-traumatic 334 7.1 (6.7–7.5) 1.08 (1.02–1.15) 1.11 (1.04–1.20)
Time since SCI 0.046 0.18
0–5 years 311 6.4 (6.0–6.8) 1 1
6–15 years 507 6.7 (6.4–7.1) 1.05 (0.97–1.14) 1.07 (0.99–1.15)
16–25 years 347 6.5 (6.1–6.9) 1.02 (0.94–1.11) 1.04 (0.95–1.14)
≥ 25 years 384 7.1 (6.7–7.4) 1.11 (1.02–1.19) 1.09 (1.01–1.19)
Unadjusted and adjusted incidence rate ratios (IRR) are from univariable and multivariable regression modelling using the negative binomial distribution 
and Wald tests for significance testing.
CI: confidence interval.
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low prevalence, heterotopic ossification (50%) (Fig. 3). Other 
commonly reported HCs of significant or chronic nature, 
including urinary tract infection and pressure ulcers, were 
associated with markedly lower rates of non-treatment 
(8.6% and 13.4%, respectively).
DISCUSSION 
This survey of Swiss community-dwelling persons 
with SCI showed a high prevalence of self-reported 
HCs. Leading HCs included spasticity, chronic pain, 
sexual dysfunction and bowel and bladder problems. 
The prevalence of HCs varied across demographic and 
SCI characteristics. Some HCs were more often reported 
by females while others were more prevalent in male 
participants. Higher age was often associated with in-
creased odds of reporting particular HCs. While lesion 
characteristics were associated with specific HCs, some 
were more prevalent in persons with paraplegia and in 
those with complete lesions (e.g. sexual dysfunction), 
while others were more often reported by people with 
incomplete lesions or tetraplegia (e.g. spasticity). Non-
traumatic aetiology was consistently associated with an 
increased frequency of reported HCs. Many SCI-specific 
HCs co-occurred. Patients reported not receiving treat-
ment for many of the HCs, even when the problem was 
viewed as significant or chronic. 
The prevalence and severity of SCI-specific HCs 
reported in this study is, to a large extent, compara-
ble to findings from other high-income settings with 
considerable investments in healthcare and similar 
life expectancy following SCI. In agreement with our 
results, a recently conducted scoping review found that the 
most common conditions, with a reported prevalence of over 
50%, were pain, bladder and bowel regulation problems, 
Fig. 2. Two-dimensional representation of the joint reporting of health conditions 
(HCs) by use of multidimensional scaling. The space between HCs provides a 
proximity measure for concurrent reporting. Symbol sizes are proportional to 
the frequency of reporting. 
Fig. 3. Rates of reporting non-treatment for health conditions (HCs) of significant or chronic severity  
(Spinal Cord Injury Secondary Conditions Scale (SCI-SCS), level 3; Appendix I). 
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as well as spasticity (5). Comparable to our findings, the 
prevalence of pressure ulcers and circulatory problems were 
between 25% and 50% (5). In a population-based study from 
Canada, Noreau et al. found the highest prevalence rates for 
urinary tract infections, spasticity and hypotension (24), while 
Adriaansen et al. found neuropathic pain, musculoskeletal pain 
and urinary tract infections to be the most frequently reported 
HCs in wheelchair-dependent persons with SCI from the 
Netherlands (4). Severity of SCI-related HCs was rated high-
est in chronic pain and sexual dysfunction in our study. This 
finding is in line with reports of pain being a severe problem 
in approximately one-third of persons with chronic pain (5, 
25). Although there are few studies on sexual dysfunction in 
SCI, our figures are higher than reported elsewhere (5, 26, 
27). Compared with other SCI studies, we found similar, to 
slightly lower, depression rates (28–30). Available estimates 
for depression in the Swiss general population are based on 
different assessment methods (31), precluding a meaningful 
comparison with our results. In line with the evidence from 
other SCI studies (32–34), the prevalence of other general 
HCs, including diabetes and cancer, appeared to be higher in 
our sample compared with the general population (35, 36).
In our study, some SCI-specific HCs were more often 
reported by women, others by men. Research on gender dif-
ferences in HCs in SCI is sparse and results are difficult to 
interpret (4). However, our results regarding general HCs, 
i.e. depression and diabetes, reflect the higher prevalence of 
depression and the lower prevalence of diabetes in the female 
general population of Switzerland (31, 35, 37), which might 
suggest that gender-differences are not affected by SCI. Con-
clusive evidence may principally come from the comparison 
of standardized, age- and sex-adjusted prevalence, but relevant 
estimates of these HCs that are based on self-report using the 
SCQ are currently not available for the Swiss general popula-
tion. In line with findings from other SCI studies (4, 24, 38), 
we observed a higher prevalence of chronic pain, contractures, 
circulatory problems, respiratory problems, heart disease, 
diabetes and cancer in the oldest age group. The middle-aged 
group reported higher prevalence of sexual dysfunction and 
sleep disorders than the younger or older age groups. In con-
trast to previous findings (24), we found a higher prevalence 
of postural hypotension in the youngest age group compared 
with the older ones. As explanations for these age differences 
are widely lacking, longitudinal analysis of objective cardio-
vascular data is warranted to clarify the role of ageing in the 
change in blood pressure regulation (5). 
Many differences in prevalence of HCs with lesion char-
acteristics, such as more respiratory problems in tetraplegia 
and a higher frequency of pressure ulcers in persons with 
complete lesions (4, 39), reflect well-known physiological 
differences. Other variations may be due to differences in 
the lived experience rather than actual differences in patho-
physiology. For example, although there is no obvious reason 
for sexual dysfunction to be more prevalent in paraplegia, 
our results may point to differential preferences of persons 
with para- and tetraplegia. This assumption is supported by 
Anderson et al. (40), who found that persons with paraplegia 
rated regaining sexual function as their highest priority to 
improve their quality of life; while for persons with tetra-
plegia restoration of arm-hand function was more important. 
The higher prevalence of self-reported HCs in persons with 
non-traumatic SCI may be explained in several ways. First, 
persons with non-traumatic SCI are, on average, older, and 
underlying causes such as ischaemia, bleeding, and tumours 
are events of older age. Secondly, causes underlying non-
traumatic SCI may additionally enhance the risk of HCs. To 
shed more light on these phenomena, multivariable analysis 
and, eventually, longitudinal studies are planned. Finally, most 
people with SCI were facing multiple HCs, and the extent of 
the multimorbidity for SCI-specific HCs varied with lesion 
characteristics and aetiology. This finding should be taken into 
consideration in the development of guidelines and policy that 
target improvements in health and community functioning, as 
well as in improving reimbursement systems by specifically 
considering the impact of multimorbidity on functioning, e.g. 
through functioning-related case-mix groups (41). 
Across HCs, there was a wide variability in the proportions of 
individuals who reported receiving treatment. While a relatively 
high proportion of those with cancer, diabetes, heart disease and 
depression received treatment, only a very low proportion of those 
with SCI-related conditions reported receiving treatment, even for 
conditions reported as significant or chronic. This lack of treat-
ment was most striking for the SCI-related HCs pain and sexual 
dysfunction. The low prevalence of reported treatment for sexual 
function may have 2 explanations: first, education and treatment 
options are not always provided, and secondly it may be the case 
that not all patients choose to seek treatment for sexual dysfunc-
tion due to social and personal inhibitions (42). Treatment rates 
might be determined by a number of factors, such as the impact 
of the disease on functioning, quality of life and mortality, the 
availability of evidence-based treatment options, the clinician’s 
and patient’s knowledge of these options, the access to treatment, 
the treatment burden (e.g. time effort, travel, costs, side-effects), 
the potential benefits and harms, and patient preferences (43). 
The present study also showed that individuals with SCI com-
monly receive simultaneous treatment for multiple HCs. In these 
individuals, clinical decision-making might also be influenced by 
considerations on the cumulative burden of pharmacological as 
well as non-pharmacological treatments, interactions between 
treatments, and the resulting need for prioritization. 
A potential limitation of the study concerns the bias intro-
duced through self-report of HCs. First, it might be the case 
that the severity of a HC is underestimated, as treatments 
reduce symptoms (e.g. pain is not declared as problem as con-
stant medication reduces pain). Secondly, existing conditions 
might not be reported, as the technical terminology used in 
the questionnaire might have caused problems. Although we 
provided explanations for technical terms, such as autonomic 
dysreflexia or heterotopic ossification, it remains unclear if all 
participants understood these. Our results on treatments raise 
2 further issues related to the problem of bias in self-report 
data. First, it must be clarified when and why persons with 
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SCI rated a condition as untreated. Was this due to insufficient 
attention of caregivers, unavailable treatment, lack of access, 
because a treatment attempt was not successful, or because 
person were not aware of treatments? Secondly, it must be 
determined in which of these conditions and to what extent an 
available treatment would result in satisfactory improvement 
in the condition. Although recall bias cannot be excluded, we 
consider the risk minimal, given that the questionnaire evalu-
ated HCs occurring in the last 3 months. Lastly, HCs that are 
considered socially undesirable, such as sexual dysfunction 
or depression (44, 45), may have been under-reported. Future 
studies that additionally involve chart review or clinical as-
sessment may conclusively verify the extent of the bias in the 
self-report of HCs and their treatment.
Acknowledging the potential limitations of self-reported 
evidence, it remains important to note that personal accounts 
of HCs and their treatment may in fact reflect the reiteration 
of clinical information that was communicated during patient 
consultation. Community follow-up in Switzerland involves 
annually scheduled check-ups to monitor patient health and 
functioning and to strengthen patient’s self-awareness and 
self-responsibility. The self-report of morbidity is increasingly 
important in the shared decision-making by medical provider 
and patient, to facilitate clinical and rehabilitation management 
that takes both clinical prognosis as well as the lived experi-
ence and needs of patients into account. In this respect, the 
present community survey provides a distinct account of the 
prevalence and severity of the HCs at stake across the differ-
ent patient groups. Further strengths of our study include its 
large sample size and the fact that the sample represents the 
Swiss SCI community (12). The study population is based on 
a large community sample rather than on a group selected by 
convenience, and the data meet high quality standards (12). 
Hence SwiSCI 2012 provides a sound basis for model-based 
future studies of the impact of socio-demographic factors and 
lesion characteristics on specific HCs. In addition, a com-
prehensive set of HCs was analysed in this study, drawing a 
detailed picture of HCs in persons with SCI. Moreover, the 
analysis was adjusted for unit as well as item non-response. 
In conclusion, the results of the present study highlight a 
high prevalence of self-reported multimorbidity in community-
dwelling persons with SCI. Treatment rates for some highly 
prevalent HCs appear to be low in Switzerland, suggesting a 
need for respective intervention. 
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APPENDIX I. Description of the methodology used to evaluate health conditions in the SwiSCI Community Survey 2012 as compared to the Spinal 
Cord Injury Secondary Conditions Scale (SCI-SCS) (15)
Original SCI-SCS introduction:
For the following 16 health problems, please rate how much each one affected your activities and independence in the last 3 months. If you have 
not experienced a secondary condition in the last 3 months or if it is an insignificant problem for you, please circle ‘’0.’’ Use the following scale to 
rate each of the secondary conditions.
SwiSCI introduction:
For the following health problems, please indicate how often these problems occurred in the last 3 months and how severe they were.
Original SCI-SCS response scale:
0=NOT experienced in the last 3 months or is an insignificant problem.
1=MILD or INFREQUENT problem.
2=MODERATE or OCCASIONAL problem.
3=SIGNIFICANT or CHRONIC problem.
SwiSCI response scale:
0=Not experienced, insignificant problem
1=Mild or infrequent problem
2=Moderate or occasional problem
3=Significant or chronic problem
SCI-SCS title SwiSCI title SCI-SCS description SwiSCI description Rating
Pressure sore(s) Pressure sores, 
decubitus
These develop as a skin rash or redness and 
progress to an infected sore. Also called skin 
ulcers, bedsores, and decubitus ulcers.
(no explanation given as it is expected that 
persons know this condition)
0 1 2 3
Injury caused by loss 
of sensation
(original) Injury may occur because of a lack of 
sensation, such as burns from carrying hot 
liquids in the lap or sitting too close to a 
heater or fire.
These are e.g. burns from carrying hot 
liquids in the lap or sitting too close to a 
heater or fire.
0 1 2 3
Muscle spasms 
(spasticity)
Muscle spasms, 
spasticity
Spasticity refers to uncontrolled, jerky muscle 
movements, such as uncontrolled muscle 
twitch or spasm. Often spasticity increases 
with infection or some kind of restriction, like 
a tight shoe or belt.
(no explanation given) 0 1 2 3
Contractures (original) A contracture is a limitation in range of 
motion caused by a shortening of the soft 
tissue around a joint, such as an elbow or 
hip. This occurs when a joint cannot move 
frequently enough through its range of 
motion. Pain often accompanies this problem.
This is a limitation in range of motion of 
a joint. 
0 1 2 3
Heterotopic bone 
ossification
(original) This is an overgrowth of bone, often 
occurring after a fracture. Early signs include 
a loss of range of motion, local swelling 
and warmth at the area to the touch. This 
condition must be diagnosed by a physician.
This is an overgrowth of bone, often 
occurring after a fracture. This condition 
must be diagnosed by a physician. 
0 1 2 3
Diabetes mellitus Diabetes
(assessed using 
SCQ)
Diabetes is a problem resulting from 
irregularities in blood sugar levels. Symptoms 
include frequent urination and excessive 
thirst. This condition is diagnosed by a 
physician.
(no explanation given) 0 1
Bladder dysfunction (original) Incontinence, bladder or kidney stones, 
kidney problems, urine leakage and urine 
back up are all symptoms of bladder 
dysfunction. NOTE: There is a separate item 
for urinary tract infections.
This includes incontinence, bladder or 
kidney stones, kidney problems, urine 
leakage and urine back up. 
0 1 2 3
Bowel dysfunction (original) Diarrhoea, constipation, ‚‘accidents,‘‘ and 
associated problems are signs of bowel 
dysfunction.
This includes diarrhoea and constipation. 0 1 2 3
Urinary tract 
infections
(original) This includes infections such as cystitis and 
pseudomonas. Symptoms include pain when 
urinating, a burning sensation throughout the 
body, blood in the urine and cloudy urine.
This includes kidney or bladder infection. 0 1 2 3
Sexual dysfunction (original) This includes dissatisfaction with sexual 
functioning. Causes for dissatisfaction can be 
decreased sensation, changes in body image, 
difficulty in movement, and problems with 
bowel or bladder, like infections.
This includes dysfunction in sexual arousal, 
erection and reaching orgasm. 
0 1 2 3
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SCI-SCS title SwiSCI title SCI-SCS description SwiSCI description Rating
Autonomic 
dysreflexia
(original) Autonomic dysreflexia, sometimes called 
hyperreflexia, results from interference in 
the body‘s temperature regulating systems. 
Symptoms of dysreflexia include sudden rises 
in blood pressure and sweating, skin blotches, 
goose bumps, pupil dilation and headache. 
It can also occur as the body‘s response to 
pain where an individual doesn‘t experience 
sensation.
Symptoms are sudden rises in blood 
pressure and sweating, skin blotches, goose 
bumps, pupil dilation and headache. 
0 1 2 3
Postural hypotension (original) This involves a strong sensation of 
lightheadedness following a change in 
position. It is caused by a sudden drop in 
blood pressure.
This involves a strong sensation of 
lightheadedness following a change in 
position. It is caused by a sudden drop in 
blood pressure. 
0 1 2 3
Circulatory problems (original) Circulatory problems involve the swelling of 
veins, feet or the occurrence of blood clots.
This involves the swelling of veins, feet or 
the occurrence of blood clots. 
0 1 2 3
Respiratory problems (original) Symptoms of respiratory infections or 
problems include difficulty in breathing and 
increased secretions.
(original) 0 1 2 3
Chronic pain Pain This is usually experienced as chronic 
tingling, burning or dull aches. It may occur 
in an area that has little to no feeling.
(no explanation) 0 1 2 3
Joint and muscle pain (not assessed 
using SCI-SCS in 
SwiSCI)
This includes pain in specific muscle 
groups or joints. People who must overuse 
a particular muscle group, such as shoulder 
muscles, or who put too much strain on their 
joints are at risk of developing pain.
0 1 2 3
(not assessed in the 
SCI-SCS)
Sleep problems This includes problems falling asleep, 
sleeping through the night and waking up 
early. 
0 1 2 3
SCQ: Self-Administered Comorbidity Questionnaire; SwiSCI: Swiss Spinal Cord Injury cohort study.
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